Cysteamine Bitartrate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Cysteamine Bitartrate
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Cysteamine Bitartrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 7 USDMF, 2 JDMF, 6 NDC API, 7 Listed Suppliers, $ API Reference Price

17 API Suppliers
7 USDMF
2 JDMF
6 NDC API
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 6 FDA Orange Book, 10 Europe, 2 Canada

18 FDF Dossiers
6 FDA Orange Book
10 Europe
2 Canada

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED RELEASE;ORAL - EQ 25MG BASE, CAPSULE, DELAYED RELEASE;ORAL - EQ 75MG BASE

CAPSULE, DELAYED RELEASE;ORAL - EQ 25MG BASE
CAPSULE, DELAYED RELEASE;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

2 Evonik, 4 SPI Pharma, 10 DKSH, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 13 Corel Pharma Chem, 3 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 8 Ideal Cures, 3 Ingredion Pharma Solutions, 10 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 16 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

56 Coating Systems & Additives, 39 Fillers, Diluents & Binders, 25 Controlled & Modified Release, 18 Thickeners and Stabilizers, 17 Disintegrants & Superdisintegrants, 15 Direct Compression, 14 Lubricants & Glidants, 13 Granulation, 12 Taste Masking, 11 Film Formers & Plasticizers, 10 Co-Processed Excipients, 9 Empty Capsules, 7 Chewable & Orodispersible Aids, 6 Solubilizers, 5 Rheology Modifiers, 5 Coloring Agents, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Topical, 2 Surfactant & Foaming Agents, 1 Parenteral

56 Coating Systems & Additives
39 Fillers, Diluents & Binders
25 Controlled & Modified Release
18 Thickeners and Stabilizers
17 Disintegrants & Superdisintegrants
15 Direct Compression
14 Lubricants & Glidants
13 Granulation
12 Taste Masking
11 Film Formers & Plasticizers
10 Co-Processed Excipients
9 Empty Capsules
7 Chewable & Orodispersible Aids
6 Solubilizers
5 Rheology Modifiers
5 Coloring Agents
5 Emulsifying Agents
4 Vegetarian Capsules
4 API Stability Enhancers
4 Topical
2 Surfactant & Foaming Agents
1 Parenteral

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 14 News #PharmaBuzz

1 Data Compilation #PharmaFlow
14 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 6 Regulatory FDF Prices

2 US Medicaid Prescriptions
6 Regulatory FDF Prices

MARKET PLACE

7 APIs, 3 FDF Dossiers

7 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

96 US Patents, 8 US Exclusivities, 4 Health Canada Patents

96 US Patents
8 US Exclusivities
4 Health Canada Patents

$ API Ref.Price (USD/KG) : 5 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Gowling WLG (Canada) LLP

filter Patent Reset all filters

4 All

01 22640531

02 22914770

filter Product Reset all filters

4 All

01 4CYSTEAMINE BITARTRATE

filter Dosage Reset all filters

4 All

01 4CAPSULE (DELAYED RELEASE)

filter Exp Date Reset all filters

4 All

01 22027-01-26

02 22034-06-17

Product Main Page

01

Gowling WLG (Canada) LLP

CYSTEAMINE BITARTRATE

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-06-17

Date Granted : 2016-09-27

CYSTEAMINE BITARTRATE

Brand Name : PROCYSBI

Patent Number : 2914770

Filing Date : 2014-06-17

Strength per Unit : 25 mg

Dosage Form : CAPSULE (DELAYED RELEASE)

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2034-06-17

Date Granted : 2016-09-27

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG (Canada) LLP

CYSTEAMINE BITARTRATE

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-01-26

Date Granted : 2017-01-03

CYSTEAMINE BITARTRATE

Brand Name : PROCYSBI

Patent Number : 2640531

Filing Date : 2007-01-26

Strength per Unit : 25 mg

Dosage Form : CAPSULE (DELAYED RELEASE)

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-01-26

Date Granted : 2017-01-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gowling WLG (Canada) LLP

CYSTEAMINE BITARTRATE

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-06-17

Date Granted : 2016-09-27

CYSTEAMINE BITARTRATE

Brand Name : PROCYSBI

Patent Number : 2914770

Filing Date : 2014-06-17

Strength per Unit : 75 mg

Dosage Form : CAPSULE (DELAYED RELEASE)

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2034-06-17

Date Granted : 2016-09-27

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG (Canada) LLP

CYSTEAMINE BITARTRATE

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-01-26

Date Granted : 2017-01-03

CYSTEAMINE BITARTRATE

Brand Name : PROCYSBI

Patent Number : 2640531

Filing Date : 2007-01-26

Strength per Unit : 75 mg

Dosage Form : CAPSULE (DELAYED RELEASE)

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-01-26

Date Granted : 2017-01-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!